{"id":"W4312139306","doi":"10.1136/ijgc-2022-igcs.534","title":"TP025/#1399 Artistry-7: phase 3 multicenter study of nemvaleukin alfa plus pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Pembrolizumab; Medicine; Ovarian cancer; Clinical endpoint; Internal medicine; Oncology; Tolerability; Carboplatin; Chemotherapy; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Cancer; Gastroenterology; Clinical trial; Immunotherapy; Cisplatin; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001247579,0.001075791,0.001508293,0.0003327172,0.0003871955,0.001069692,0.0008973851,0.001058045,0.004844991],"category_scores_gemma":[0.0007351299,0.000411319,0.001408186,0.0002895509,0.0007817604,0.0009053564,0.0003096942,0.003440551,0.001029322],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008433845,"about_ca_system_score_gemma":0.00157202,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001294393,"about_ca_topic_score_gemma":0.00411711,"domain_scores_codex":[0.9997014,0.0001477674,0.0000119534,0.00004357174,0.00002451734,0.00007069662],"domain_scores_gemma":[0.9995694,0.00006916237,0.00006936397,0.00003035841,0.00002632486,0.0002354657],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8236415,0.04721032,0.003759004,0.0008699154,0.002382327,0.0001449995,0.0002099166,0.001971433,0.02437015,0.0004688006,0.005937022,0.08903468],"study_design_scores_gemma":[0.740005,0.2457254,0.00758574,0.00004422852,0.0006783353,0.0001165967,0.0000799477,0.001264109,0.001800395,0.0002064711,0.002467904,0.00002586754],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908271,0.002430644,0.0004258047,0.0007511801,0.0002778175,0.001627452,0.001214555,0.0001178718,0.002327475],"genre_scores_gemma":[0.9863619,0.001989157,0.001494234,0.001283354,0.0002330768,0.002206766,0.002321135,0.00004026278,0.004070263],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004844991,"threshold_uncertainty_score":0.01620811,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02582260374654257,"score_gpt":0.3340360980159985,"score_spread":0.308213494269456,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}